Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.50%
#3 Helium Helium +29.80%
#4 Pons Pons +28.26%
#5 TENDIES TENDIES +23.40%
#6 龙虾 (Lobster) 龙虾 (Lobster) +19.97%
#7 o1.exchange o1.exchange +18.32%
#8 Main Street Yield Main Street Yield +17.48%
#9 Nillion Nillion +16.96%
#10 Giggle Fund Giggle Fund +15.80%
Coin of the day
GEKKO GEKKO
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
शेयरों में रैंक #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
शेयर मूल्य
$9.60
अंतिम समन्वयन: 2025-05-21
मार्केट कैप
$1.08B
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार OptiNose, Inc. (OPTN)

श्रेणी

Healthcare
OptiNose, Inc. (OPTN) के लिए बकाया शेयरों की संख्या
March 2025 की स्थिति में बकाया शेयरों की संख्या: 11.67M
OptiNose, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 11.67M है। December 2023 के अंत में कंपनी के पास 112.08M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
OptiNose, Inc. (OPTN) के लिए 2015 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
वर्ष बकाया शेयर परिवर्तन
2026 (TTM) 11.67M 14.88%
2024 10.16M -90.94%
2023 112.08M 1,857.16%
2022 5.73M -89.93%
2021 56.85M 17.77%
2020 48.28M 15.28%
2019 41.88M 5.31%
2018 39.77M 18.80%
2017 33.47M 1,131.11%
2016 2.72M -89.82%
2015 26.72M 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
कंपनी बकाया शेयर अंतर देश
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 20,463.38%
IN